Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)

China · Delayed Price · Currency is CNY

72.11

-0.06 (-0.08%)

Jun 27, 2025, 3:00 PM CST

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
Recombinant Protein Drugs, Health Consulting and Medical Services	2.10B	Log In	Log In	Log In	Log In	Upgrade
Recombinant Protein Drugs, Health Consulting and Medical Services Growth	38.46%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
China	2.09B	Log In	Log In	Log In	Log In	Upgrade
China Growth	38.07%	Log In	Log In	Log In	Log In	Upgrade
Overseas	4.02M	Log In	Log In	Log In	Log In	Upgrade
Overseas Growth	-3.63%	Log In	Log In	Log In	Log In	Upgrade